Special Research Initiatives - Grant ID: SR0567658
Funder
Australian Research Council
Funding Amount
$100,000.00
Summary
A cross-disciplinary collaboration to develop a national system for real-time detection of Adverse Drug Reactions using linked Australian health data. Our aim is to use existing administrative health data in the evidence-based, cost-effective and privacy-respecting discovery of Adverse Drug Reactions. This research is of vital importance, since adverse reactions to medicines currently represent one of the leading causes of hospitalisation and death in Australia. In a groundbreaking collaboration ....A cross-disciplinary collaboration to develop a national system for real-time detection of Adverse Drug Reactions using linked Australian health data. Our aim is to use existing administrative health data in the evidence-based, cost-effective and privacy-respecting discovery of Adverse Drug Reactions. This research is of vital importance, since adverse reactions to medicines currently represent one of the leading causes of hospitalisation and death in Australia. In a groundbreaking collaboration, we have successfully shown that large linked, administrative data sets are sufficiently rich to enable discovery of adverse drug reactions, but our analytic tools are at an early developmental stage. The outcome of this project would be innovative, effective and sustainable analytic tools for the discovery of unexpected associations between drugs and medical events.Read moreRead less
Development of computer-based decision support tools using population pharmacokinetic/pharmacodynamic models. Diabetes is an epidemic that presents an enormous burden to health systems of both developed and developing nations. Australia spends an estimated $35 billion on the condition annually, with costs set to rise with increasing diagnosis rates. Additionally, the burden of diabetes is more prominent in indigenous Australians. We intend to improve management of this disease in non-indigenous ....Development of computer-based decision support tools using population pharmacokinetic/pharmacodynamic models. Diabetes is an epidemic that presents an enormous burden to health systems of both developed and developing nations. Australia spends an estimated $35 billion on the condition annually, with costs set to rise with increasing diagnosis rates. Additionally, the burden of diabetes is more prominent in indigenous Australians. We intend to improve management of this disease in non-indigenous and indigenous Australians by development of a user-friendly computer-based decision support tool for doctors. Once established, this tool will have applications in other fields of health care where support is needed to make informed dosing decisions for critical medications and have the potential to reduce financial and social impacts of chronic disease.Read moreRead less